Clinical characterization of status epilepticus in childhood: a retrospective study in 124 patients

D Chiarello1, F Duranti1, A Lividini1

  • 1Child Neurology and Psychiatry Unit, S Orsola Malpighi Hospital, University of Bologna, Bologna, Italy.

Seizure
|May 7, 2020
PubMed

Insights

This study analyzed pediatric status epilepticus (SE) and refractory SE (RSE), finding non-antiepileptic treatments and comorbidities significantly influence acute etiology and nonconvulsive SE (NCSE). NCSE, acute, and idiopathic-cryptogenic etiologies are common in RSE.

Area of Science:

  • Pediatric Neurology
  • Epileptology

Background:

  • Status epilepticus (SE) is a neurological emergency in children.
  • Refractory SE (RSE) presents a significant clinical challenge.
  • Understanding SE/RSE demographics, semiology, and etiology is crucial for effective management.

Purpose of the Study:

  • To describe demographic data, semiology, and etiology in pediatric patients with SE and RSE.
  • To identify factors associated with RSE and specific SE subtypes.
  • To inform clinical suspicion and management strategies for SE/RSE.

Main Methods:

  • Retrospective review of pediatric patients (2 months to 18 years) diagnosed with SE.
  • Inclusion criteria: SE diagnosis, admission between January 2001 and December 2016, and available clinical data.
  • Analysis of demographic data, semiology, etiology, and treatment associations.

Main Results:

  • 124 pediatric patients were included; mean age 4.6 years.
  • Focal convulsive-SE was most common (50.8%), followed by generalized (32.3%) and nonconvulsive SE (NCSE) (16.9%).
  • Febrile SE common in younger children, idiopathic-cryptogenic in older. Chemotherapy, PRES associated with NCSE. RSE occurred in 17.7%, often with NCSE, acute, or idiopathic-cryptogenic etiologies (encephalitis, unknown epilepsy).

Conclusions:

  • Non-antiepileptic treatments (chemotherapy, dialysis) and comorbidities (PRES) significantly impact acute etiology and NCSE.
  • NCSE, acute (encephalitis), and idiopathic-cryptogenic (unknown epilepsy) etiologies are frequently observed in RSE.
  • A high level of clinical suspicion is recommended for these conditions in pediatric SE/RSE management.
Abstract